Sera Prognostics Q2 revenue rises on expanded partnerships and Medicaid coverage

Sera Prognostics

12/08/2026 21:28

Overview
US pregnancy diagnostics firm's Q2 revenue rose yr/yr, driven by expanded partnerships and Medicaid coverage
Company's Q2 net loss widened as operating expenses increased for commercial execution and strategic hires
Company ended Q2 with $80.3 mln in cash and securities, funding operations through 2029 milestones

Outlook
Company expects research and development expenses to decline in future periods
Company expects current cash to fund operations through commercialization milestones through 2029
Sera Prognostics expects to complete CE marking submission in Europe in Q4 2026

Result Drivers
PARTNERSHIP EXPANSION - Co said launch of fourth partnership program and expanded payer engagement contributed to increased adoption of PreTRM test
MEDICAID COVERAGE - Illinois Medicaid mandate expanded access to PreTRM test, covering all Medicaid pregnancies in the state
INCREASED TESTING VOLUME - Co said steady month-to-month increase in testing volume followed publication of PRIME study data

Company press release: ID:nPn62dhzsa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Loss Per Share
 
$0.18
 

Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Sera Prognostics, Inc. is $5.50, about 176.4% above its August 11 closing price of $1.99

Reuters Recommended Reads
Aug 10 - Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Aug 12 - Bio-Techne beats revenue estimates on research, diagnostics demand uptick
Aug 12 - BioCardia Q2 net loss narrows on lower R&D costs

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)